Skip to content
← Back to this collection

PUBLICATIONS · 21848522

Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Haematol
Publication date
2011 Oct
First author
Becker PS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Becker PS
      type
      Author
    2. name
      Kantarjian HM
      type
      Author
    3. name
      Appelbaum FR
      type
      Author
    4. name
      Petersdorf SH
      type
      Author
    5. name
      Storer B
      type
      Author
    6. name
      Pierce S
      type
      Author
    7. name
      Shan J
      type
      Author
    8. name
      Hendrie PC
      type
      Author
    9. name
      Pagel JM
      type
      Author
    10. name
      Shustov AR
      type
      Author
    11. name
      Stirewalt DL
      type
      Author
    12. name
      Faderl S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Becker PS
      type
      Author
    2. name
      Kantarjian HM
      type
      Author
    3. name
      Appelbaum FR
      type
      Author
    4. name
      Petersdorf SH
      type
      Author
    5. name
      Storer B
      type
      Author
    6. name
      Pierce S
      type
      Author
    7. name
      Shan J
      type
      Author
    8. name
      Hendrie PC
      type
      Author
    9. name
      Pagel JM
      type
      Author
    10. name
      Shustov AR
      type
      Author
    11. name
      Stirewalt DL
      type
      Author
    12. name
      Faderl S
      type
      Author
    bibliography ids
    1. nci-bib-adad659adab55fa444fd440f
    book metadata
    content sha256
    c85652327f9ec6bec5005f0675590b1b0dfe84b5d048431bc875a3d81d0dc714
    document type
    citation
    dois
    1. 10.1111/j.1365-2141.2011.08831.x
    electronic publication date
    display
    2011 Aug 18
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21848522
    immutable id
    pubmed:21848522@c85652327f9ec6bec5005f0675590b1b0dfe84b5d048431bc875a3d81d0dc714
    journal
    abbreviation
    Br J Haematol
    issn electronic
    1365-2141
    issn print
    0007-1048
    issue
    2
    name
    British journal of haematology
    nlm unique id
    0372544
    pages
    182-9
    volume
    155
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21848522
      provenance
      batch id
      2529ef2eca926738ab13
      provider
      NCBI PubMed ESummary
      record sha256
      a33892c3c5e3c6a4bfb5bf0073fd98ef2df4190ad219ba9115824a0c96b4228f
      response sha256
      9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
      retrieved at
      2026-09-09T23:46:42.856296+00:00
      publication date
      display
      2011 Oct
      precision
      month
      year
      2011
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21848522/
      title
      Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.

      Preserved source evidence · Not medical advice